Boryung Pharm’s antihypertensive Kanarb family achieves over KRW 5 billion monthly sales

The Boryung Pharm’s ‘Kanarb(generic name: fimasartan) family,’ Korea’s first novel hypertension treatments, achieved KRW 5 billion monthly prescriptions.

The Boryung Pharm’s Kanarb family, including 4 drugs, such as Kanarb, Kanarb Plus(diuretic, Dong Wha Pharm’s Korean product name: Lacor), Dukarb(combination drug with amlodipine) and Tuvero(combination drug with rosuvastatin), recorded KRW 5....